Summary
- Current Price
- As of today, CADL price is $12.35, down -8.52% on
- Current Price All-Time High
- CADL price is currently -16.44% below its historical high of $14.78 set on
- Market Cap
- CADL current market cap is $945M, up +197.35% over the past 365 days
- Revenue
- CADL current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for CADL is on
Profile
| Metric | Value |
|---|---|
| Full Name | Candel Therapeutics, Inc. |
| Ticker | NASDAQ: CADL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | candeltx.com |
| Employees | 38 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $12.35 | |
| Price, 1D Change | -8.52% | |
| $945M | ||
| - | ||
| - | ||
| 1.89 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.72 | ||
| EPS, 1Y Change | +58.61% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.72 | ||
| EPS Estimate | -$0.95 | N/A |
| EPS Est. Change | -31.07% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $12.35 | |
| Price Target | $22.50 | - |
| Price Tgt. Change | +82.19% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.14 | -$1.74 | -52.33% | |
| -$0.63 | -$0.72 | -15.36% | |
| -$0.95 | N/A | -31.07% | |
| -$1.43 | N/A | -98.34% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $42.78M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $12.35 | |
| $6.94 | ||
| $9.98 | ||
| $7.74 | ||
| $10.09 | ||
| $0.75 | ||
| 1.89 | ||
| $0.74 | ||
| 64.25 | ||
| 94.10% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$0.72 | ||
| -$845.00K | ||
| - | ||
| -$48.27M | ||
| - | ||
| -$38.18M | ||
| - | ||
| -$47.42M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.94 | ||
| 13.49 | ||
| 13.49 | ||
| - | ||
| - | ||
| 4.93 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 7.49 | ||
| -11.12 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $51.92M | ||
| $119.73M | ||
| $125.63M | ||
| $121.39M | ||
| $73.71M | ||
| $9.00M | ||
| $49.03M | ||
| $445.00K | ||
| $1.13M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $38.18M | ||
| $47.42M | ||
| $845.00K | ||
| $0.00 | ||
| $845.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$38.31M | ||
| -$560.00K | ||
| $56.10M | ||
| $587.00K | ||
| -$38.90M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| B of A Securities | → | |
| HC Wainwright & Co. | → | |
| Stifel | ||
| Cantor Fitzgerald | ||
| Citigroup | → | |
| Citigroup | → | |
| Canaccord Genuity | → | |
| Stephens & Co. | → | |
| Freedom Broker | → | |
| Citigroup | → |
Analyst sentiment
Institutional ownership
Screeners with CADL
FAQ
- What is the ticker symbol for Candel Therapeutics, Inc.?
- The ticker symbol for Candel Therapeutics, Inc. is NASDAQ:CADL
- Does Candel Therapeutics, Inc. pay dividends?
- No, Candel Therapeutics, Inc. does not pay dividends
- What sector is Candel Therapeutics, Inc. in?
- Candel Therapeutics, Inc. is in the Healthcare sector
- What industry is Candel Therapeutics, Inc. in?
- Candel Therapeutics, Inc. is in the Biotechnology industry
- What country is Candel Therapeutics, Inc. based in?
- Candel Therapeutics, Inc. is headquartered in United States
- When did Candel Therapeutics, Inc. go public?
- Candel Therapeutics, Inc. initial public offering (IPO) was on July 27, 2021
- Is Candel Therapeutics, Inc. in the S&P 500?
- No, Candel Therapeutics, Inc. is not included in the S&P 500 index
- Is Candel Therapeutics, Inc. in the NASDAQ 100?
- No, Candel Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Candel Therapeutics, Inc. in the Dow Jones?
- No, Candel Therapeutics, Inc. is not included in the Dow Jones index
- When was Candel Therapeutics, Inc. last earnings report?
- Candel Therapeutics, Inc.'s most recent earnings report was on August 13, 2026
- When does Candel Therapeutics, Inc. report earnings?
- The next expected earnings date for Candel Therapeutics, Inc. is November 12, 2026
Data Sources & References
- CADL Official Website www.candeltx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1841387/000119312526103134/0001193125-26-103134-index.htm
- CADL Profile on Yahoo Finance finance.yahoo.com/quote/CADL
- CADL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cadl